Warning letterFDA · Jan 13, 2026
Center For Immunology Science, LLC MARCS-CMS 719933, January 13, 2026
Named company: Center For Immunology Science, LLC
The Center for Immunology Science’s failure to submit, and to have in effect, an IND before initiating Protocol CISMX-001 with an investigational drug raises significant concerns about the safety and welfare…
